+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Viscosupplementation Market Research Report by Product (Five Injection, Single Injection, and Three Injection), Source, Application, End-use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 232 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4986027
UP TO OFF until Dec 31st 2022
The Global Viscosupplementation Market size was estimated at USD 2,529.64 million in 2021, USD 2,678.74 million in 2022, and is projected to grow at a CAGR 6.07% to reach USD 3,602.76 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Viscosupplementation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Five Injection, Single Injection, and Three Injection.
  • Based on Source, the market was studied across Animal and Nonanimal.
  • Based on Application, the market was studied across Hand Osteoarthritis, Hip Osteoarthritis, and Knee Osteoarthritis.
  • Based on End-use, the market was studied across Hospitals and Orthopedic Clinics/Ambulatory Surgical Centers (ASCs).
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Delaware, Georgia, Illinois, Minnesota, New Hampshire, Pennsylvania, Tennessee, Vermont, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Viscosupplementation market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Viscosupplementation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Viscosupplementation Market, including AbbVie Inc., Alcon Inc., Anika Therapeutics, Inc., Avanos Medical, Inc., Bausch Health Companies Inc., Bioventus LLC, Contipro A.S., F. Hoffmann-La Roche AG, Ferring B.V., Fidia Farmaceutici S.p.A., Gentex Pharma, LLC, LG Life Sciences Ltd., Lifecore Biomedical, LLC, Quimfa S.A., Regen Lab SA, Sanofi S.A., Seikagaku Corporation, Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zimmer Biomet.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Viscosupplementation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viscosupplementation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viscosupplementation Market?
4. What is the competitive strategic window for opportunities in the Global Viscosupplementation Market?
5. What are the technology trends and regulatory frameworks in the Global Viscosupplementation Market?
6. What is the market share of the leading vendors in the Global Viscosupplementation Market?
7. What modes and strategic moves are considered suitable for entering the Global Viscosupplementation Market?
Frequently Asked Questions about the Global Viscosupplementation Market

What is the estimated value of the Global Viscosupplementation Market?

The Global Viscosupplementation Market was estimated to be valued at $2529.64 Million in 2021.

What is the growth rate of the Global Viscosupplementation Market?

The growth rate of the Global Viscosupplementation Market is 6.0%, with an estimated value of $3602.76 Million by 2027.

What is the forecasted size of the Global Viscosupplementation Market?

The Global Viscosupplementation Market is estimated to be worth $3602.76 Million by 2027.

Who are the key companies in the Global Viscosupplementation Market?

Key companies in the Global Viscosupplementation Market include AbbVie Inc., Alcon Inc., Anika Therapeutics, Inc., Avanos Medical, Inc., Bausch Health Companies Inc., Bioventus LLC, Contipro A.S., F. Hoffmann and Ferring B.V..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
5.1.1.3. Surge in Geriatric Population and Obesity Globally
5.1.2. Restraints
5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
5.1.3. Opportunities
5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
5.1.4. Challenges
5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
5.2. Cumulative Impact of COVID-19
6. Viscosupplementation Market, by Product
6.1. Introduction
6.2. Five Injection
6.3. Single Injection
6.4. Three Injection
7. Viscosupplementation Market, by Source
7.1. Introduction
7.2. Animal
7.3. Nonanimal
8. Viscosupplementation Market, by Application
8.1. Introduction
8.2. Hand Osteoarthritis
8.3. Hip Osteoarthritis
8.4. Knee Osteoarthritis
9. Viscosupplementation Market, by End-use
9.1. Introduction
9.2. Hospitals
9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
10. Americas Viscosupplementation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Viscosupplementation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Viscosupplementation Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. AbbVie Inc.
14.2. Alcon Inc.
14.3. Anika Therapeutics, Inc.
14.4. Avanos Medical, Inc.
14.5. Bausch Health Companies Inc.
14.6. Bioventus LLC
14.7. Contipro A.S.
14.8. F. Hoffmann-La Roche AG
14.9. Ferring B.V.
14.10. Fidia Farmaceutici S.p.A.
14.11. Gentex Pharma, LLC
14.12. LG Life Sciences Ltd.
14.13. Lifecore Biomedical, LLC
14.14. Quimfa S.A.
14.15. Regen Lab SA
14.16. Sanofi S.A.
14.17. Seikagaku Corporation
14.18. Smith & Nephew PLC
14.19. Teva Pharmaceutical Industries Ltd.
14.20. Viatris Inc.
14.21. Zimmer Biomet
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL VISCOSUPPLEMENTATION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET DYNAMICS
FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2021 VS 2027 (%)
FIGURE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2021 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2027
FIGURE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 25. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2027
FIGURE 27. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2021 VS 2027 (%)
FIGURE 34. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2021 VS 2027 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2027
FIGURE 36. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 42. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2027
FIGURE 44. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. CANADA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 50. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2027
FIGURE 52. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 54. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2027
FIGURE 56. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. CHINA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. INDIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 70. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2027
FIGURE 71. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. ITALY VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. QATAR VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. GLOBAL VISCOSUPPLEMENTATION MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 83. GLOBAL VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 84. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VISCOSUPPLEMENTATION MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 33. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 34. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 36. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 39. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 41. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 44. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 49. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 50. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 52. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2019-2027 (USD MILLION)
TABLE 55. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY STATE, 2019-2027 (USD MILLION)
TABLE 57. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 64. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 65. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 67. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 68. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 69. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 70. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 72. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 73. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 74. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 75. CANADA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 77. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 78. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 79. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 80. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 82. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 83. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 84. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 85. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 87. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 88. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 89. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 90. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 91. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 94. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 95. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 96. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 97. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 99. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 100. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 101. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 102. CHINA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 104. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 105. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 106. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 107. INDIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 109. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 110. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 111. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 112. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 114. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 115. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 116. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 117. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 119. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 120. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 121. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 122. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 124. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 125. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 126. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 127. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 129. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 130. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 131. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 132. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 134. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 135. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 136. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 137. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 139. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 140. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 141. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 142. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 144. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 145. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 146. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 147. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 149. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 150. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 151. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 158. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 159. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 160. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 161. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 162. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 163. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 164. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 165. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 166. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 167. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 168. ITALY VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 169. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 170. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 171. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 172. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 173. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 175. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 176. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 177. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 178. QATAR VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 180. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 181. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 182. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 183. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 184. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 185. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 186. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 187. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 188. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 189. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 190. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 191. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 192. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 193. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 194. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 195. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 196. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 197. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 198. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 199. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 200. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 201. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 202. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 208. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 209. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 210. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2019-2027 (USD MILLION)
TABLE 211. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 212. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
TABLE 213. GLOBAL VISCOSUPPLEMENTATION MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 214. GLOBAL VISCOSUPPLEMENTATION MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 215. GLOBAL VISCOSUPPLEMENTATION MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 216. GLOBAL VISCOSUPPLEMENTATION MARKET RANKING
TABLE 217. GLOBAL VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2021
TABLE 218. GLOBAL VISCOSUPPLEMENTATION MARKET MERGER & ACQUISITION
TABLE 219. GLOBAL VISCOSUPPLEMENTATION MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 220. GLOBAL VISCOSUPPLEMENTATION MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 221. GLOBAL VISCOSUPPLEMENTATION MARKET INVESTMENT & FUNDING
TABLE 222. GLOBAL VISCOSUPPLEMENTATION MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 223. GLOBAL VISCOSUPPLEMENTATION MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Alcon Inc.
  • Anika Therapeutics, Inc.
  • Avanos Medical, Inc.
  • Bausch Health Companies Inc.
  • Bioventus LLC
  • Contipro A.S.
  • F. Hoffmann-La Roche AG
  • Ferring B.V.
  • Fidia Farmaceutici S.p.A.
  • Gentex Pharma, LLC
  • LG Life Sciences Ltd.
  • Lifecore Biomedical, LLC
  • Quimfa S.A.
  • Regen Lab SA
  • Sanofi S.A.
  • Seikagaku Corporation
  • Smith & Nephew PLC
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zimmer Biomet

Methodology

Loading
LOADING...